SEC 13F Intelligence

Silvercrest Asset Management Group LLC / ABT

Silvercrest Asset Management Group LLC’s Abbott Laboratories Position

Does Silvercrest Asset Management Group LLC own Abbott Laboratories (ABT)? Yes — 1.09M shares worth $112M (+0.81% of its 13F portfolio) as of Q1 2026, down from 1.12M shares the prior filed quarter.

Position Value
$112M
Q1 2026
Shares
1.09M
% of Portfolio
+0.81%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $130MQ4 ’18Q1 ’19: $143MQ2 ’19: $150MQ3 ’19: $149MQ4 ’19: $155MQ4 ’19Q1 ’20: $138MQ2 ’20: $139MQ3 ’20: $163MQ4 ’20: $164MQ4 ’20Q1 ’21: $181MQ2 ’21: $143MQ3 ’21: $142MQ4 ’21: $169MQ4 ’21Q1 ’22: $125MQ2 ’22: $114MQ3 ’22: $98MQ4 ’22: $140MQ4 ’22Q1 ’23: $132MQ2 ’23: $155MQ3 ’23: $133MQ4 ’23: $145MQ4 ’23Q1 ’24: $145MQ2 ’24: $129MQ3 ’24: $138MQ4 ’24: $145MQ4 ’24Q1 ’25: $165MQ2 ’25: $165MQ3 ’25: $157MQ4 ’25: $141MQ4 ’25Q1 ’26: $112Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.09M$112M+0.81%
Q4 20251.12M$141M+0.97%
Q3 20251.17M$157M+1.04%
Q2 20251.21M$165M+1.11%
Q1 20251.24M$165M+1.18%
Q4 20241.28M$145M+0.97%
Q3 20241.21M$138M+0.94%
Q2 20241.24M$129M+0.88%
Q1 20241.27M$145M+0.98%
Q4 20231.31M$145M+1.02%
Q3 20231.38M$133M+1.01%
Q2 20231.42M$155M+1.10%
Q1 20231.31M$132M+1.00%
Q4 20221.28M$140M+1.08%
Q3 20221.02M$98M+0.81%
Q2 20221.04M$114M+0.86%
Q1 20221.06M$125M+0.81%
Q4 20211.20M$169M+1.07%
Q3 20211.20M$142M+0.96%
Q2 20211.23M$143M+0.94%
Q1 20211.51M$181M+1.22%
Q4 20201.50M$164M+1.20%
Q3 20201.50M$163M+1.40%
Q2 20201.52M$139M+1.23%
Q1 20201.75M$138M+1.48%
Q4 20191.79M$155M+1.20%
Q3 20191.78M$149M+1.23%
Q2 20191.79M$150M+1.41%
Q1 20191.78M$143M+1.40%
Q4 20181.80M$130M+1.43%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Silvercrest Asset Management Group LLC’s full portfolio or all institutional holders of ABT.